Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -365.03%-314.26M | 53.27%-264.78M | 125.91%118.57M | 74.87%-566.65M | 66.52%-457.64M | -45.50%-2.25B | -317.70%-1.37B | 41.84%-1.55B | 30.20%-327.28M | 0.63%-2.66B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 45.62%-85.17M | ---- | 35.00%-156.63M | ---- | 46.70%-240.96M | ---- | 41.68%-452.13M | ---- | 58.15%-775.3M |
| Dividend (income)- adjustment | ---- | 95.79%-1.28M | ---- | -34.24%-30.39M | ---- | -456.70%-22.64M | ---- | 90.80%-4.07M | ---- | 74.61%-44.2M |
| Impairment and provisions: | ---- | -48.37%134.21M | ---- | -78.69%259.93M | ---- | 37.77%1.22B | ---- | -59.90%885.23M | ---- | -23.55%2.21B |
| -Other impairments and provisions | ---- | -48.37%134.21M | ---- | -78.69%259.93M | ---- | 37.77%1.22B | ---- | -59.90%885.23M | ---- | -14.46%2.21B |
| Revaluation surplus: | ---- | -151.92%-105.36M | ---- | -39.27%202.91M | ---- | -26.68%334.11M | ---- | 3.76%455.67M | ---- | 32.96%439.18M |
| -Other fair value changes | ---- | -151.92%-105.36M | ---- | -39.27%202.91M | ---- | -26.68%334.11M | ---- | 3.76%455.67M | ---- | 32.96%439.18M |
| Asset sale loss (gain): | ---- | ---- | ---- | -108.58%-2.06M | ---- | -1.03%23.95M | ---- | 161.58%24.2M | ---- | 103.42%9.25M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | 52.80%40.84M | ---- | --26.73M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---387K | ---- | ---- | ---- | 10.75%-4.93M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | 87.55%-2.06M | ---- | -552.45%-16.51M | ---- | -117.84%-2.53M | ---- | 105.35%14.18M |
| Depreciation and amortization: | ---- | -91.07%2.85M | ---- | -54.70%31.93M | ---- | 11.13%70.5M | ---- | -17.22%63.44M | ---- | -48.73%76.64M |
| -Depreciation | ---- | -91.07%2.85M | ---- | -54.70%31.93M | ---- | 11.13%70.5M | ---- | -17.22%63.44M | ---- | -48.73%76.64M |
| Financial expense | ---- | -19.33%264.02M | ---- | -13.73%327.3M | ---- | -21.38%379.37M | ---- | -29.83%482.56M | ---- | -56.89%687.71M |
| Special items | 57.98%486.36M | ---- | -75.41%307.87M | 5,185.34%13.53M | -47.75%1.25B | 97.99%-266K | 554.92%2.4B | ---13.26M | -40.95%365.87M | ---- |
| Operating profit before the change of operating capital | -59.64%172.1M | -169.52%-55.51M | -46.32%426.44M | 116.27%79.85M | -22.81%794.42M | -355.01%-490.81M | 2,566.63%1.03B | -70.88%-107.87M | -74.39%38.59M | -44.16%-63.12M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -51.15%265.16M | ---- | 12,024.23%542.79M | ---- | 93.37%-4.55M | ---- | -28.43%-68.61M | ---- | -119.76%-53.42M |
| Accounts payable increase (decrease) | ---- | 12.44%-58.78M | ---- | 65.63%-67.13M | ---- | 56.94%-195.31M | ---- | 21.74%-453.61M | ---- | 39.36%-579.58M |
| prepayments (increase)decrease | ---- | -16.73%24.51M | ---- | -71.49%29.44M | ---- | 218.89%103.25M | ---- | -755.45%-86.84M | ---- | -90.86%13.25M |
| Financial assets at fair value (increase)decrease | ---- | 0.09%291.11M | ---- | -75.78%290.83M | ---- | 24.26%1.2B | ---- | -36.57%966.25M | ---- | -85.22%1.52B |
| Special items for working capital changes | ---- | -83.80%4.46M | ---- | -77.31%27.54M | ---- | -87.36%121.38M | ---- | 462.25%960.07M | ---- | -68.59%-265.03M |
| Cash from business operations | -59.64%172.1M | -47.86%470.95M | -46.32%426.44M | 22.97%903.33M | -22.81%794.42M | -39.26%734.59M | 2,566.63%1.03B | 110.15%1.21B | -74.39%38.59M | -93.98%575.48M |
| Other taxs | ---- | -70.93%-2.02M | ---- | -101.72%-1.18M | -100.97%-722K | 554.82%68.47M | 707.07%74.18M | 87.12%-15.05M | 90.33%-12.22M | -2,307.19%-116.89M |
| Interest received - operating | -63.84%4.54M | -75.11%21.02M | -36.37%12.55M | 90.32%84.46M | -50.34%19.72M | -78.67%44.38M | -68.87%39.7M | -62.07%208.06M | -73.79%127.52M | -63.81%548.56M |
| Net cash from operations | -59.76%176.64M | -50.34%489.95M | -46.03%438.99M | 16.42%986.61M | -28.84%813.42M | -39.57%847.44M | 642.74%1.14B | 39.25%1.4B | -69.87%153.89M | -90.91%1.01B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | -95.79%1.28M | --780K | 34.24%30.39M | ---- | 456.70%22.64M | 1,228.17%20.14M | -90.80%4.07M | 321.11%1.52M | -74.30%44.2M |
| Sale of fixed assets | ---- | ---- | ---- | ---- | --465K | --752K | ---- | ---- | ---- | -63.98%6.49M |
| Purchase of fixed assets | ---- | ---- | ---- | 21.61%-874K | -7.77%-874K | -13.54%-1.12M | 43.25%-811K | 82.13%-982K | 61.50%-1.43M | 93.62%-5.5M |
| Sale of subsidiaries | ---- | ---- | ---- | -62.39%65.31M | ---- | 6.25%173.66M | ---- | --163.44M | ---- | ---- |
| Recovery of cash from investments | -17.95%59.03M | 176.61%74.32M | 563.48%71.94M | -76.87%26.87M | 218.95%10.84M | -94.47%116.16M | ---9.12M | 54.85%2.1B | ---- | -17.63%1.36B |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.59B | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | 492.62%3.46M | -39.97%428K | 169.49%583K | 2,128.13%713K | -1,087.06%-839K |
| Net cash from investment operations | -18.83%59.03M | -37.88%75.6M | 596.97%72.72M | -61.44%121.69M | -1.92%10.43M | -86.10%315.56M | -99.33%10.64M | 61.87%2.27B | 103.81%1.59B | -11.75%1.4B |
| Net cash before financing | -53.95%235.66M | -48.97%565.55M | -37.89%511.7M | -4.70%1.11B | -28.59%823.85M | -68.33%1.16B | -33.86%1.15B | 52.41%3.67B | 35.10%1.74B | -80.98%2.41B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 102.88%36.28M | --186.3M | ---1.26B | ---- | ---- | ---- | ---- | ---- | ---- | -95.69%831.57M |
| Refund | ---- | -89.46%-1.46B | ---- | 69.71%-769.57M | 105.73%20.18M | -12.77%-2.54B | 55.96%-351.97M | 63.28%-2.25B | 84.09%-799.24M | 79.06%-6.14B |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | --3.85B | ---- | ---- | ---- | --1.55B |
| Interest paid - financing | -7,342.00%-125.99M | 65.90%-111.45M | 98.95%-1.69M | 19.09%-326.84M | 24.77%-160.9M | 51.68%-403.95M | 57.39%-213.86M | -18.56%-836M | -58.16%-501.87M | 51.87%-705.1M |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | 84.93%-31.58M | ---- | ---209.51M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---1.69B | ---- | ---- | ---- | ---- |
| Other items of the financing business | 18.33%-169.39M | 5.49%-362.49M | -31.48%-207.41M | -78.03%-383.53M | -384.88%-157.75M | 46.48%-215.43M | 59.99%-32.53M | -271.73%-402.51M | -116.91%-81.31M | 51.53%-108.28M |
| Net cash from financing operations | 82.31%-259.98M | -15.79%-1.75B | -349.91%-1.47B | -42.65%-1.51B | 50.40%-326.68M | 70.19%-1.06B | 59.33%-658.63M | 23.95%-3.55B | 43.56%-1.62B | 60.48%-4.66B |
| Effect of rate | -322.71%-9.65M | 52.01%12.89M | -79.18%4.33M | -69.82%8.48M | 35.43%20.81M | 3,267.98%28.1M | 498.55%15.36M | 95.75%-887K | 85.80%-3.86M | -331.65%-20.88M |
| Net Cash | 97.46%-24.32M | -195.10%-1.18B | -292.71%-958.09M | -479.41%-400.24M | 0.43%497.17M | -15.38%105.49M | 297.19%495.02M | 105.53%124.66M | 107.90%124.63M | -361.87%-2.26B |
| Begining period cash | -73.88%413.12M | -19.85%1.58B | -19.85%1.58B | 7.26%1.97B | 6.49%1.97B | 6.93%1.84B | 7.70%1.85B | -56.96%1.72B | -56.96%1.72B | 27.27%4B |
| Items Period | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -647.38%-4.56M | ---92K | ---610K |
| Cash at the end | -39.59%379.15M | -73.88%413.12M | -74.81%627.6M | -19.85%1.58B | 5.41%2.49B | 7.26%1.97B | 28.36%2.36B | 6.93%1.84B | -23.03%1.84B | -56.96%1.72B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | 29.72%2.35B | --1.76B | --1.81B | ---- |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | 29.72%2.35B | --1.76B | --1.81B | ---- |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.